Varex Imaging

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in July 2016 and is headquartered in Salt Lake City, UT.

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Varex Imaging meets Q1 expectations amidst gross margin challenges

Varex Imaging's Q1 performance met expectations, with revenue impacted by a less favorable product mix. The company faces challenges from cautious customer behavior and gross margin pressures but sees opportunities in the healthcare market, particularly in China.

Varex Imaging excels in Q2, plans expansion amid supply challenges

Varex Imaging delivered strong Q2 results, driven by robust performance in the Industrial segment and innovative projects in Medical and Industrial segments.
While facing supply chain challenges, the company aims to invest in expanding manufacturing capacity to address demand and ensure operational resilience.
With a positive outlook for fiscal 2023 and a focus on cost management, Varex is poised for continued growth and market leadership in the imaging industry.

Varex Imaging achieves record revenue in Q3 2023 earnings

Varex Imaging delivered a robust performance in Q3 2023, marked by record revenue, improved margins, and strong segment growth.
While facing supply chain and market challenges, the company remains optimistic about sustained growth and profitability.
Strategic focus on new products, margin enhancement, and key segment expansion positions Varex well for future success.

Varex Imaging posts strong Q4 results, eyes growth opportunities

Varex Imaging reports solid Q4 performance with revenue driven by Industrial segment. Challenges include decline in Medical segment revenue and anticipated revenue decrease in Q1 FY 2024. Company focuses on growth opportunities in photon counting technology, India expansion, and new product introductions.

Varex Imaging meets Q1 expectations, focuses on photon counting growth

Varex Imaging's Q1 performance met expectations, with revenue at $190 million and a focus on new product development in photon counting technology.
While facing challenges in certain modalities and markets, the company showcased strength in global Industrial sales and employee pride.
Opportunities lie in the photon counting technology for CT, revenue growth expectations for Q2, and stable operational environment post-supply chain issues.
Management's forward-looking approach towards customer successes and technology advancements positions Varex Imaging for future growth and market expansion.

Varex Imaging faces revenue challenges in China, eyes tech growth

Varex Imaging's Q2 performance reflected mixed results with revenue, gross margin, and EPS figures. While facing challenges from soft demand in China, the company is focusing on leveraging photon-counting technology for future growth opportunities.

Varex Imaging meets Q3 revenue expectations amidst market challenges

Varex Imaging's Q3 performance was solid, with strengths in cargo inspection products and financial stability.
Challenges in China and the Medical segment require strategic focus for sustained growth.
Opportunities lie in market improvements, managing demand effectively, and exploring new growth avenues.

Varex Imaging reports resilient Q4 performance and outlines growth strategies

Varex Imaging's Q4 performance showcased revenue resilience in the industrial segment but faced challenges in medical segment revenue.
The company's strategic focus on innovation and expansion presents growth opportunities in dynamic markets.
Balancing revenue diversification, margin maintenance, and operational efficiency will be key for future success.
Anticipated revenue growth in Q1 2025 with a range of $195-215 million and varied EPS expectations.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Varex Imaging Corp. engages in the design, manufacture, and sale of imaging components. It operates through the Medical and Industrial segments. The Medical segment delivers and services x-ray imaging components, including X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, and three-dimensional reconstruction software. The Industrial segment offers x-ray imaging products for use in security, and nondestructive testing and inspection applications. The company was founded in 2016 and is headquartered in Salt Lake City, UT.

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the fourth quarter of fiscal year 2023. Q4 FY23 Summary Revenues of $227 million GAAP gross margin 34% | Non-GAAP gross margin* 36% GAAP operating expense $54 million | Non-GAAP operating expense* $51 million GAAP operating margin 11% | Non-GAAP operating margin* 13% GAAP net income $0.66 per diluted share | Non-GAAP net income* $0.45 per diluted share Cash flow from ope.

Varex Announces Financial Results for Fourth Quarter and Fiscal Year 2023

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the fourth quarter and full fiscal year 2023 following the close of regular trading on Tuesday, November 14, 2023. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at www.vareximaging.com/investor-relations/. Investors can also acc.

Varex Schedules Fourth Quarter and Fiscal Year 2023 Earnings Release and Conference Call

Blue Bird

EZCORP

Great Lakes Dredge & Dock

Willdan Group

Penny stocks can be tempting because of their low price, but investors should beware. Here's why you should avoid them, plus five alternative investments with better risk/reward profiles.

5 Best Penny Stock Alternatives To Buy In October 2023

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Sidoti Small Cap Virtual Conference. Management will participate in a fireside chat presentation on Wednesday, September 20, 2023 at 1:00pm EST. The presentation will be webcast live and may be accessed through the following link: https://sidoti.zoom.us/webinar/register/WN_b584FfbtSOy7pvg9PiEx5g A replay of the presentation will be available on Varex's website.

Varex to Present at the Sidoti Small Cap Virtual Conference

Varex Imaging Corporation (NASDAQ:VREX ) Q3 2023 Earnings Conference Call August 1, 2023 5:00 PM ET Company Participants Christopher Belfiore - Investor Relations Sunny Sanyal - President and Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer & Company Larry Solow - CJS Young Li - Jefferies James Sidoti - Sidoti & Company Anthony Petrone - Mizuho Securities Operator Greetings. Welcome to the Varex Third Quarter Full Year 2023 Earnings Call.

Varex Imaging Corporation (VREX) Q3 2023 Earnings Call Transcript

VAREX IMAGING (VREX) came out with quarterly earnings of $0.37 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.20 per share a year ago.

VAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the third quarter of fiscal year 2023. 3QFY23 Summary Revenues $232 million GAAP gross margin 33% | Non-GAAP gross margin* 34% GAAP operating margin 10% | Non-GAAP operating margin* 13% GAAP net earnings $0.21 per diluted share | Non-GAAP net earnings* $0.37 per diluted share Cash flow from operations $38 million “We are pleased to report another solid quarter, with reve.

Varex Announces Financial Results for Third Quarter Fiscal Year 2023

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the third quarter of fiscal year 2023 following the close of regular trading on Tuesday, August 1, 2023. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day. This call will be webcast live and can be accessed at the company's website at https://www.vareximaging.com/investor-relations/. Investors can also acces.

Varex Schedules Third Quarter Fiscal Year 2023 Earnings Release and Conference Call

Boston Scientific

Investors with an interest in Medical - Products stocks have likely encountered both VAREX IMAGING (VREX) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?

VREX vs. BSX: Which Stock Is the Better Value Option?

Haemonetics

Investors interested in stocks from the Medical - Products sector have probably already heard of VAREX IMAGING (VREX) and Haemonetics (HAE). But which of these two companies is the best option for those looking for undervalued stocks?

VREX or HAE: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Products stocks are likely familiar with VAREX IMAGING (VREX) and Haemonetics (HAE). But which of these two stocks offers value investors a better bang for their buck right now?

VREX vs. HAE: Which Stock Is the Better Value Option?

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Healthcare Conference. Management will participate in a fireside chat presentation on Wednesday, June 7, 2023 at 3:30pm EST. The presentation will be webcast live and may be accessed through the following link: https://wsw.com/webcast/jeff281/vrex/1883310. A replay of the presentation will be available on Varex's website at www.vareximaging.com/news.

Varex to Present at the Jefferies Healthcare Conference

Deutsche Bank

General Motors

StoneCo

Unum

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Deutsche Bank (DB), General Motors (GM), Unum Group (UNM), StoneCo Ltd.

5 Valuable Price-to-Book Stocks to Boost Your Portfolio

EssilorLuxottica SA

Investors interested in Medical - Products stocks are likely familiar with VAREX IMAGING (VREX) and EssilorLuxottica Unsponsored ADR (ESLOY). But which of these two companies is the best option for those looking for undervalued stocks?

VREX vs. ESLOY: Which Stock Should Value Investors Buy Now?

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Deutsche Bank (DB), General Motors (GM), Unum Group (UNM), PVH Corp. (PVH) and Varex Imaging Corporation (VREX) are some such stocks.

Add These 5 Low Price-to-Book Stocks to Your Portfolio in May

Does VAREX IMAGING (VREX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Here's Why VAREX IMAGING (VREX) is a Great Momentum Stock to Buy

VAREX IMAGING (VREX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's What You Should Know

Flowserve

Ligand Pharmaceuticals

VREX, LGND and FLS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 5, 2023.

Best Momentum Stocks to Buy for May 5th

Kennametal

Ranger Energy Services

SIGA Technologies

VREX, LGND, RNGR, SIGA and KMT have been added to the Zacks Rank #1 (Strong Buy) List on May 5, 2023.

New Strong Buy Stocks for May 5th

VAREX IMAGING (VREX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Surging Earnings Estimates Signal Upside for VAREX IMAGING (VREX) Stock

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today the launch of its XRD 3131N digital X-ray detector, addressing the growing need for faster and more comprehensive inspection in high-paced Electric Vehicle (EV) battery manufacturing, strengthening our current portfolio for the EV battery inspection market. XRD 3131N enables a rapid and more thorough inspection process Engineered for high inspection throughput in 24/7 manufacturing cycles Powers premium qu.

Varex Launches XRD 3131N X-Ray Detector for High Throughput Electric Vehicle Battery Inspection

Varex Imaging Corporation (NASDAQ:VREX ) Q2 2023 Earnings Conference Call May 2, 2023 5:00 PM ET Company Participants Christopher Belfiore - Director of Investor Relations Sunny Sanyal - President and Chief Executive Officer Sam Maheshwari - Chief Financial Officer Conference Call Participants Larry Solow - CJS Securities Young Li - Jefferies Jim Sidoti - Sidoti & Company Operator Greetings, and welcome to the Varex Second Quarter Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Varex Imaging Corporation (VREX) Q2 2023 Earnings Conference Call Transcript

VAREX IMAGING (VREX) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.37 per share a year ago.

VAREX IMAGING (VREX) Q2 Earnings and Revenues Beat Estimates

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced its unaudited financial results for the second quarter of fiscal year 2023. 2QFY23 Summary Revenues $228 million GAAP gross margin 32% | Non-GAAP gross margin* 33% GAAP operating margin 7% | Non-GAAP operating margin* 10% GAAP net earnings $0.10 per diluted share | Non-GAAP net earnings* $0.26 per diluted share Cash flow from operations $27 million “We are pleased to report results for the second quarter t.

Varex Announces Strong Financial Results for Second Quarter Fiscal Year 2023

SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) today announced that it will report unaudited financial results for the second quarter of fiscal year 2023 following the close of regular trading on Tuesday, May 2, 2023. The earnings news release will be followed by a conference call at 3:00 pm Mountain Time that day.

News for Varex Imaging Stock (VREX)